Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), sold 219,348 shares at $5.77 ($1.3M) on 2018-06-08, disclosed to the SEC on 2018-06-12.
Open-market sale of $1.3M GALT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.77 | 104,294 | $602K | 47.3% |
| 2 | $5.77 | 104,294 | $602K | 47.3% |
| 3 | $6.50 | 10,760 | $70K | 5.5% |
| Total | $5.81 avg | 219,348 | $1.3M | 100% |
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |